Adjunctive and novel therapies for sepsis

Area of Science:

• Pediatric critical care medicine
• Infectious diseases
• Pharmacology

Background:

• Sepsis is a significant cause of illness and death in children.
• Current sepsis management focuses on early antibiotics and shock resuscitation.
• Despite optimal care, pediatric sepsis continues to pose a major health challenge.

Purpose of the Study:

• To review the rationale and evidence for adjunctive therapies in pediatric sepsis.
• To explore novel treatment strategies beyond standard care.
• To identify areas for future research in sepsis management.

Main Methods:

• Literature review of existing evidence on adjunctive sepsis therapies.
• Analysis of studies on extracorporeal support, immunomodulation, and mitochondria-targeted treatments.
• Synthesis of findings to assess therapeutic potential and limitations.

Main Results:

• Adjunctive therapies, including extracorporeal support, show potential benefits in sepsis management.
• Immunomodulatory and mitochondria-targeted therapies are emerging as promising avenues.
• Evidence for these novel approaches in pediatric sepsis is still developing.

Conclusions:

• Adjunctive therapies offer potential to improve outcomes in pediatric sepsis.
• Further research is critical to define optimal patient selection, timing, and application.
• Personalized approaches are needed to maximize the efficacy of these interventions.